NFKB1 and cancer: Moreover, the severity of inflammation could also be a predictor of progression or cancer outcome such as in the case of pancreatic cancer, where the high metastatic potential, chemoresistance and poor prognosis are closely related to the activation of nuclear factor-kB (NFkB) and give the mechanistic link to chronic inflammation in pancreatic cancer development [47].